Navigation Links
Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
Date:1/4/2008

- VELCADE(R) (bortezomib) for Injection sales grew 20% to $265 million in

2007- - sNDA submitted for VELCADE expansion into front-line multiple myeloma - - MLN0002 core bridging studies fully enrolled, showing favorable results -

- New proteasome inhibitor, MLN2238, enters development pipeline -

- On track to exceed 2007 net income financial guidance -

CAMBRIDGE, Mass., Jan. 4 /PRNewswire-FirstCall/ -- Building on a record year in 2007, Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced 2008 corporate goals and financial guidance. These goals, along with selected financial and operational results from 2007, will be presented at the 26th Annual JPMorgan Healthcare Conference on January 9, 2008, in San Francisco, Calif.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

"The past year was the most successful in the Company's 15-year history with outstanding accomplishments across commercial, R&D and operations. Millennium is well positioned for strong growth in 2008 and beyond," said Deborah Dunsire, M.D., President and Chief Executive Officer, Millennium. "The expected launch in front-line multiple myeloma is the next catalyst for VELCADE. Our late-stage product candidate, MLN0002, is approaching pivotal trials in inflammatory bowel diseases, representing the next revenue growth driver, and our innovative R&D organization continues to fuel the pipeline. We begin 2008 in the strongest financial position in the Company's history and remain firmly committed to continued top- and bottom-line growth."

In 2008, the Company's goals will focus on three strategic
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection
2. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
3. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
4. Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market
5. Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
6. Millennium to Webcast Third-Quarter 2007 Financial and Operational Results
7. Life Sciences Leader Joins Millennium Board of Directors
8. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
9. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
10. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
11. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just praying that ... few doctors said he had a good chance of ... her now 20-month-old son, Kaiba. "At that point, we ... it and run with it." , They found hope ...
(Date:5/23/2013)... CASTLE ROCK, Colo. , May 23, 2013 /PRNewswire/ ... vitro diagnostic company focused on obtaining FDA clearance ... APPY1 , today announced the pricing of an underwritten ... and related warrants to purchase 3,500,000 shares of its ... share at a combined public offering price of $1.25 ...
(Date:5/23/2013)... May 23, 2013  BioScrip, Inc. (NASDAQ: ... at the Jefferies 2013 Global Healthcare Conference to be ... York. Richard Smith , ... Tran , Chief Financial Officer, will present on ... Time.   About BioScrip BioScrip, Inc. ...
(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...
Breaking Biology Technology:Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3
... - Sonic Foundry, Inc. , has announced it ... shares of common stock at $3.75 per share. ... close on Dec. 27, 2006, will be used to ... the company's search technology and intellectual property protection. The ...
... segment of a national and international pipeline to Wisconsin might ... CellCura, Inc. , a Norwegian biotechnology and stem cell research ... Research Park . , ,CellCura, the fourth stem cell company ... years, chose Madison following an international search and will open ...
... TomoTherapy executives have talked about their ... are bearing fruit. , ,The Madison-based medical technology ... Kirloskar Theratronics, Ltd . to distribute ... countries. KTPL, part of the Kirloskar Group, provides ...
Cached Biology Technology:CellCura could start an invasion of stem cell firms 2CellCura could start an invasion of stem cell firms 3
(Date:5/23/2013)... in Plant Science , Automated ... content and promoter evolution among grasses , Within ... stretches of DNA that undergo little change in position ... code for any proteins. Some of these evolutionarily stable ... regulate the expression of other genes or the condensation ...
(Date:5/23/2013)... fruit, can be made both better-tasting and longer-lasting thanks ... "Working with GM tomatoes that are different to normal ... allows us to pinpoint exactly how to breed in ... Innes Centre. , The research could also lead to ... characteristics because even higher levels of the compounds can ...
(Date:5/23/2013)... Northwest National Laboratory honored more than 165 staff ... property at PNNL,s annual Intellectual Property Commercialization Recognition ... of Energy national laboratory named materials scientist Jun ... developing battery materials that can store large amounts ... and reduce the time it takes to charge ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3The world's favorite fruit only better-tasting and longer-lasting 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... the University of Cincinnati (UC) shows that high-fat diets, ... can inflame fat tissue surrounding blood vessels, possibly contributing ... in the Feb. 20 edition of the American Heart ... MD, and colleagues examined adipose tissueor fatsurrounding the coronary ...
... research trip to Puerto Rico, ecologist James Porter took samples ... evidence of radioactive matter instead he found a link ... life were to unexploded bombs from the World War II ... of carcinogenic materials. "Unexploded bombs are in the ...
... scientists claim that the degeneration of sight, caused by a ... by increasing the amount of fruit, vegetables and nuts in ... cause of blindness in the UK, with 45% of those ... results in a gradual loss of central vision, due to ...
Cached Biology News:High-fat diets inflame fat tissue around blood vessels, contribute to heart disease 2Link between unexploded munitions in oceans and cancer-causing toxins determined 2Diet could reduce onset of eye disease by 20 percent 2
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L....
Request Info...
...
Geneticin Selective Antibiotic liquid...
Biology Products: